Price Momentum and Recent Performance
Chandan Healthcare’s current price of ₹231.30 marks a significant recovery from its previous close of ₹222.55, reflecting a daily gain of 3.93%. This uptick is particularly striking against the backdrop of the stock’s 52-week low of ₹185.40 and a 52-week high of ₹358.00, indicating that while the stock remains well below its peak, it is attempting to regain upward momentum.
Over the past week, the stock has surged 16.91%, vastly outperforming the Sensex, which declined by 0.89% in the same period. However, the longer-term returns paint a more cautious picture: a 1-month gain of 2.19% contrasts with the Sensex’s 4.77% loss, but year-to-date, Chandan Healthcare has fallen 28.73%, significantly underperforming the Sensex’s 11.74% decline. Over one year, the stock’s return of -7.03% is slightly better than the Sensex’s -7.96%, yet the absence of data for three, five, and ten-year returns underscores its micro-cap status and limited historical trading volume.
Technical Indicator Analysis
The technical landscape for Chandan Healthcare is nuanced. The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly timeframe, signalling that the stock’s momentum is still under pressure despite recent gains. The monthly MACD data is unavailable, which limits a longer-term momentum assessment. Meanwhile, the Relative Strength Index (RSI) shows no clear signal on either weekly or monthly charts, suggesting the stock is neither overbought nor oversold at present.
Bollinger Bands on both weekly and monthly charts indicate sideways movement, reflecting a consolidation phase where price volatility is contained within a narrow range. This sideways trend is consistent with the stock’s recent mild recovery but also signals caution as the stock has yet to break decisively into a bullish phase.
Daily moving averages have shifted to mildly bearish, reinforcing the notion that while short-term price action is positive, the overall trend remains fragile. The KST (Know Sure Thing) indicator on the weekly chart is bearish, further confirming the lack of strong upward momentum. Dow Theory assessments align with this view, showing mildly bearish trends on both weekly and monthly timeframes.
On-balance volume (OBV) readings are mildly bearish across weekly and monthly periods, indicating that volume trends do not strongly support the recent price gains. This divergence between price and volume suggests that the rally may lack conviction from institutional investors or broader market participation.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Mojo Score and Market Capitalisation Context
Chandan Healthcare holds a Mojo Score of 37.0, categorised as a Sell rating, downgraded from a previous Hold on 10 August 2026. This downgrade reflects the deteriorating technical and fundamental outlook for the stock. The company is classified as a micro-cap, which typically entails higher volatility and lower liquidity, factors that investors should weigh carefully.
The hospital sector, to which Chandan Healthcare belongs, has faced headwinds amid evolving healthcare demands and competitive pressures. The stock’s underperformance relative to the Sensex over the year-to-date period underscores sector-specific challenges and company-specific risks.
Comparative Returns and Sectoral Implications
While Chandan Healthcare’s recent weekly return of 16.91% is impressive, it is important to contextualise this within its broader performance. The stock’s year-to-date loss of 28.73% is more than double the Sensex’s decline of 11.74%, signalling significant underperformance. This disparity suggests that despite short-term technical improvements, the stock faces structural challenges that may limit sustained recovery.
Investors should also note the absence of long-term return data for three, five, and ten years, which may reflect the company’s relatively recent listing or limited trading history. In contrast, the Sensex has delivered robust long-term returns, including 17.22% over three years and 161.14% over ten years, highlighting the broader market’s resilience compared to this micro-cap hospital stock.
Why settle for Chandan Healthcare Ltd? SwitchER evaluates this Hospital micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Technical Outlook and Investor Considerations
The shift from a bearish to mildly bearish technical trend suggests that Chandan Healthcare is at a critical juncture. The stock’s recent price appreciation may attract short-term traders looking to capitalise on momentum, but the lack of strong confirmation from key indicators such as MACD, RSI, and OBV advises caution.
Investors should monitor the stock’s ability to sustain above its daily moving averages and watch for any bullish crossover in MACD or a breakout from the Bollinger Bands’ sideways range. A failure to do so could see the stock revert to its prior bearish trend, especially given the micro-cap risks and sector headwinds.
Given the current Mojo Grade of Sell and the downgrade from Hold, a conservative approach is warranted. Investors with a higher risk tolerance may consider tactical entries on dips, but a clear improvement in volume and momentum indicators would be necessary to justify a more bullish stance.
In summary, Chandan Healthcare Ltd’s technical parameters reveal a tentative recovery amid persistent bearish undertones. The stock’s recent gains are encouraging but require confirmation through sustained volume and momentum improvements before a definitive trend reversal can be declared.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
